2023
DOI: 10.2147/jir.s396914
|View full text |Cite
|
Sign up to set email alerts
|

Risk Genetic Variants (IL-10) for Osteoporosis in Han Population from Northwest China

Abstract: Background: Osteoporosis (OP) is a common metabolic bone disease characterized by loss of bone mass. IL-10 is considered to be a powerful immune and inflammatory suppressor. This study aimed to assess association between genetic loci in IL-10 and susceptibility to OP. Methods: Association analysis between IL-10 genetic loci and OP risk through SNPStats online software. FPRP analysis (falsepositive report probability) verified whether the positive results were noteworthy findings. Linkage disequilibrium (LD) an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…However, its expression decreases in a high-glucose environment, leading to osteoblast proliferation disorder [16]. IL10, renowned for its potent immune and inflammatory suppression properties, is thought to inhibit bone resorption and reduce bone loss [17], but some studies have proved that IL10 is significantly increasing in DM patients [18,19], which also just goes to show that DOP development and its regulatory mechanisms are quite complex. Moving on to IL17A, a proinflammatory cytokine, it can indirectly stimulate bone resorption by RANKL (receptor activator of NF-κB ligand) [20,21].…”
Section: Discussionmentioning
confidence: 99%
“…However, its expression decreases in a high-glucose environment, leading to osteoblast proliferation disorder [16]. IL10, renowned for its potent immune and inflammatory suppression properties, is thought to inhibit bone resorption and reduce bone loss [17], but some studies have proved that IL10 is significantly increasing in DM patients [18,19], which also just goes to show that DOP development and its regulatory mechanisms are quite complex. Moving on to IL17A, a proinflammatory cytokine, it can indirectly stimulate bone resorption by RANKL (receptor activator of NF-κB ligand) [20,21].…”
Section: Discussionmentioning
confidence: 99%